ArticleCancer reports (Hoboken, N.J.)2022

The cost, survival, and quality-of-life implications of guideline-discordant imaging for prostate cancer.

Aaron N Winn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.